Inactive

Title: Advanced Sequencing Analysis Document Type: Combined Synopsis / Solicitation Notice Solicitation Number: 75N91021Q00264 Proposed Posted Date: 9/1/2021 Proposed Response Date: 9/7/2021 Classific... Title: Advanced Sequencing Analysis Document Type: Combined Synopsis / Solicitation Notice Solicitation Number: 75N91021Q00264 Proposed Posted Date: 9/1/2021 Proposed Response Date: 9/7/2021 Classification Code: R499 – Support – Professional - Other NAICS Code: 541990 – All other Professional, Scientific and Technical Services Business Size Standard: $15 million Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E122, Bethesda, MD 20892, UNITED STATES. Description of Requirement The National Cancer Institute (NCI), Center for Cancer Research (CCR) would like to procure study to investigate how immune cells interact with tumor cells in a tumor microenvironment. This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation that will not be issued. This solicitation: No. 75N91021Q00264 includes all applicable provisions and clauses in effect through FAR FAC 2021-06 (July 2021) simplified procedures for commercial items. The North American Industry Classification System code is 541990 and the business size standard is $15 million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. BACKGROUND This study will investigate how immune cells interact with tumor cells in a tumor microenvironment. The National Cancer Institute (NCI), will collect six lung cancer and leukemia tumor samples to be sent to for advanced sequencing analysis. Once complete, those results will be returned to NCI for downstream analysis. OBJECTIVE The primary objective of this project is to perform advanced sequencing (so called spatial-transcriptomic analysis) that can identify 1000 genes with their spatial location and generate RNA expression data for 6 samples. SCOPE This study will analyze the gene expression with their spatial-information in tumor samples. CONTRACT REQUIREMENTS/ AND PERSONNEL QUALIFICATIONS (IF APPLICABLE) The contractor shall perform the following tasks: NCI will send six FFPE slides that are collected on IRB approved clinical protocol so that advanced sequencing with spatial-information on those slides can be performed. TYPE OF ORDER This will be issued as a Severable Firm Fixed Price Purchase Order. PERIOD OF PERFORMANCE The period of performance shall be from September 20, 2021 to December 19, 2021. PLACE OF PERFORMANCE The work shall be performed at the Contractor’s facility. DELIVERY / INSTALLATION The deliverables shall be sent to the Contracting Officer Representative (COR) on the due date for the respective task. The COR will be designated at the time of award. REPORT(S)/DELIVERABLES AND DELIVERY SCHEDULE DELIVERABLE DELIVERABLE DESCRIPTION / FORMAT REQUIREMENTS DUE DATE (Task 1) Sequencing results in electronic FASTQ format of slides 1, 2 & 3 10/1/2021 (Task 2) Sequencing results in electronic FASTQ format of slides 4, 5 & 6 11/1/2021 *FASTQ format: a text file that contains the sequence data